OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression

Humana and Evolent expand partnership to enhance oncology care

Humana Inc. and Evolent Health Inc. announced an expansion of their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services.

November 15, 2024

Vol.50 No.43

Clinical Trials & Tribulations

A simple intervention could help address overlooked pain among older adults with cancer in rural America

A recent article in JAMA Network Open published by myself and my research collaborators—Jill Harrison at Brown University, Sarah Yarborough at Fred Hutch, and Tammy Stokes at Maury Regional Medical Center—examined the potential for a brief communication-based intervention to help older adults with cancer who live in rural settings better manage their pain.

September 13, 2024

Vol.50 No.34

By Megan J. Shen

Guest Editorial Satire

A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.

Sometimes profoundly important public health opportunities are discovered by accident.

July 05, 2024

Vol.50 No.27

By Michael A. Friedman

Clinical

RWE study pinpoints gaps in mental health care utilization among parents of children with cancer

Unquestionably, a child’s cancer diagnosis weighs heavily on the parents’ minds. But now, an analysis of nearly 30,000 U.S. families has quantified how often parents of children with cancer use mental health services.

May 17, 2024

Vol.50 No.20

By McKenzie Prillaman

Drugs & Targets

Shasqi, Johnson & Johnson expand existing research collaboration

Shasqi, Inc. and Johnson & Johnson Enterprise Innovation Inc. have expanded their ongoing research collaboration.

October 13, 2023

Vol.49 No.38

Drugs & Targets

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Pierre Fabre Laboratories and Vernalis, a fully owned subsidiary of HitGen Inc., established a long-term partnership to identify pre-clinical candidates against oncology targets.

September 29, 2023

Vol.49 No.36

OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression

YOU MAY BE INTERESTED IN

Humana and Evolent expand partnership to enhance oncology care

A simple intervention could help address overlooked pain among older adults with cancer in rural America

A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.

RWE study pinpoints gaps in mental health care utilization among parents of children with cancer

Shasqi, Johnson & Johnson expand existing research collaboration

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Renew today!

Subscriber content

Never miss an issue!

Login

OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression

YOU MAY BE INTERESTED IN

Humana and Evolent expand partnership to enhance oncology care

A simple intervention could help address overlooked pain among older adults with cancer in rural America

A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supplyWarning: This is not a public health recommendation. Do not implement.

RWE study pinpoints gaps in mental health care utilization among parents of children with cancer

Shasqi, Johnson & Johnson expand existing research collaboration

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Never miss an issue!

Login

A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.